Tags

Type your tag names separated by a space and hit enter

Successful treatment of periungual warts with diluted bleomycin using translesional multipuncture technique: a pilot prospective study.
Dermatol Surg. 2011 Apr; 37(4):486-92.DS

Abstract

BACKGROUND

The treatment of periungual warts is a therapeutic challenge. Various treatment modalities can be ineffective and may cause scarring and permanent nail changes.

OBJECTIVES

A prospective pilot study to investigate the efficacy and safety of a low concentration (0.1 U/mL) of bleomycin in the treatment of periungual warts.

METHODS

Periungual warts were injected with bleomycin (0.1 U/mL) every 4 weeks until elimination of the lesions or until the injections were discontinued because of adverse effects. Bleomycin was administered using the translesional multipuncture technique.

RESULTS

We recruited 15 patients with periungual warts from March 2007 to March 2008. Thirteen patients were male (86.6%); median age was 30. Seven patients (46.6%) demonstrated complete clearance 1 month after the first injection; two required two treatment sessions. Thirteen (86.6%) patients had complete clearance of the treated wart at the 6-month follow-up with only one injection. Wart recurrence was observed in two patients. All patients were followed for 6 months after the initial treatment. No significant long-term adverse effects were noted. Only one patient demonstrated mild postinflammatory hyperpigmentation, which resolved after 1 month, and nine (60%) had localized moderate pain for 2 to 3 days after the injection.

CONCLUSION

Translesional multipuncture treatment with a low concentration (0.1 U/mL) of bleomycin is an effective modality for periungual warts that results in minimal side effects. Larger controlled studies are needed.

Authors+Show Affiliations

Department of Dermatology, College of Medicine, King Saud University, Riyadh, Saudi Arabia. kmgderm@yahoo.comNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article

Language

eng

PubMed ID

21414076

Citation

AlGhamdi, Khalid M., and Huma Khurram. "Successful Treatment of Periungual Warts With Diluted Bleomycin Using Translesional Multipuncture Technique: a Pilot Prospective Study." Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.], vol. 37, no. 4, 2011, pp. 486-92.
AlGhamdi KM, Khurram H. Successful treatment of periungual warts with diluted bleomycin using translesional multipuncture technique: a pilot prospective study. Dermatol Surg. 2011;37(4):486-92.
AlGhamdi, K. M., & Khurram, H. (2011). Successful treatment of periungual warts with diluted bleomycin using translesional multipuncture technique: a pilot prospective study. Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.], 37(4), 486-92. https://doi.org/10.1111/j.1524-4725.2011.01932.x
AlGhamdi KM, Khurram H. Successful Treatment of Periungual Warts With Diluted Bleomycin Using Translesional Multipuncture Technique: a Pilot Prospective Study. Dermatol Surg. 2011;37(4):486-92. PubMed PMID: 21414076.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Successful treatment of periungual warts with diluted bleomycin using translesional multipuncture technique: a pilot prospective study. AU - AlGhamdi,Khalid M, AU - Khurram,Huma, Y1 - 2011/03/17/ PY - 2011/3/19/entrez PY - 2011/3/19/pubmed PY - 2011/6/17/medline SP - 486 EP - 92 JF - Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] JO - Dermatol Surg VL - 37 IS - 4 N2 - BACKGROUND: The treatment of periungual warts is a therapeutic challenge. Various treatment modalities can be ineffective and may cause scarring and permanent nail changes. OBJECTIVES: A prospective pilot study to investigate the efficacy and safety of a low concentration (0.1 U/mL) of bleomycin in the treatment of periungual warts. METHODS: Periungual warts were injected with bleomycin (0.1 U/mL) every 4 weeks until elimination of the lesions or until the injections were discontinued because of adverse effects. Bleomycin was administered using the translesional multipuncture technique. RESULTS: We recruited 15 patients with periungual warts from March 2007 to March 2008. Thirteen patients were male (86.6%); median age was 30. Seven patients (46.6%) demonstrated complete clearance 1 month after the first injection; two required two treatment sessions. Thirteen (86.6%) patients had complete clearance of the treated wart at the 6-month follow-up with only one injection. Wart recurrence was observed in two patients. All patients were followed for 6 months after the initial treatment. No significant long-term adverse effects were noted. Only one patient demonstrated mild postinflammatory hyperpigmentation, which resolved after 1 month, and nine (60%) had localized moderate pain for 2 to 3 days after the injection. CONCLUSION: Translesional multipuncture treatment with a low concentration (0.1 U/mL) of bleomycin is an effective modality for periungual warts that results in minimal side effects. Larger controlled studies are needed. SN - 1524-4725 UR - https://www.unboundmedicine.com/medline/citation/21414076/Successful_treatment_of_periungual_warts_with_diluted_bleomycin_using_translesional_multipuncture_technique:_a_pilot_prospective_study_ L2 - https://onlinelibrary.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=1076-0512&date=2011&volume=37&issue=4&spage=486 DB - PRIME DP - Unbound Medicine ER -